nach oben

Clinical Rheumatology

Erschienen in:

17.02.2018 | Review Article

Reactive arthritis: update 2018

verfasst von: A. García-Kutzbach, J. Chacón-Súchite, H. García-Ferrer, I. Iraheta

Erschienen in: Clinical Rheumatology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

At this time, reactive arthritis (ReA) is considered to be part of the spectrum of the spondyloarthritis, previously known as Reiter’s syndrome, and refers to an infection induced systemic illness, characterized by a sterile synovitis occurring in a genetically predisposed individual, secondary to an infection localized in a distant organ/system, but also accompanied with multiple extra articular manifestations.

Keynan Y, Rimar D (2008) Reactive arthritis—the appropriate name. Isr Med Assoc J 10(4):256–258PubMed

Panush R, Wallace D, Dorff R, Engleman E (2007) Retraction of the suggestion to use the term «Reiter’s syndrome» sixty-five years later. Arthritis Rheum 56(2):693–694. https://doi.org/10.1002/art.22374 CrossRefPubMed

Stavropoulos P, Soura E, Kanelleas A, Katsambas A, Antoniou C (2015) Reactive arthritis. J Eur Acad Dermatology Venereol 29(3):415–424. https://doi.org/10.1111/jdv.12741 CrossRef

Hannu T (2011) Reactive arthritis. Best Pract Res Clin Rheumatol 25(3):347–357. https://doi.org/10.1016/j.berh.2011.01.018 CrossRefPubMed

Colmegna I, Cuchacovich R, Espinoza L (2004) HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev 17(2):348–369. https://doi.org/10.1128/CMR.17.2.348 CrossRefPubMedPubMedCentral

Gupta R, Misra R (2016) Microbe-triggered arthropathies: reactive arthritis and beyond. Int J Rheum Dis 19(5):437–439. https://doi.org/10.1111/1756-185X.12920 CrossRefPubMed

Lopez Férez F, García Novo E (1986) Tratados hipocráticos. (eds) Gredos, Madrid, España

Allison D (1980) Christopher Columbus: first case of Reiter’S disease in the old world? Lancet 316(8207):1309. https://doi.org/10.1016/S0140-6736(80)92381-8 CrossRef

Carter J, Hudson A (2009) Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin N Am 35(1):21–44. https://doi.org/10.1016/j.rdc.2009.03.010 CrossRef

10.

Manasson J, Shen N, García H, Ubeda C, Iraheta I, Heguy A, Von Feldt J, Espinoza L, García Kutzbach A, Segal L, Ogdie A, Clemente J, Sher J (2017) Gut microbiota perturbations in reactive arthritis and post-infectious Spondyloarthritis arthritis. Rheum. https://doi.org/10.1002/art.40359 [Epub ahed of print]

11.

Ehrenfeld M (2010) Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 9(5):A325–A329. https://doi.org/10.1016/j.autrev.2009.11.012 CrossRefPubMed

12.

Szamocki S, Martyn-hemphill C, Green J (2016) Reactive arthritis: can’t see, can’t pee, can’t climb a tree. Trends Urol Men’s Heal 7(1):17–20. https://doi.org/10.1002/tre.501 CrossRef

13.

García-Kutzbach A, Montenegro A, Iraheta I, Bará C, Saénz R (2011) Epidemiology of spondyloarthropathies in Central America. Am J Med Sci 341(4):295–297. https://doi.org/10.1097/MAJ.0b013e31820f8cf1 CrossRefPubMed

14.

Brewerton D, Hart F, Nicholls A, Caffrey M, James D, Sturrock R (1973) Ankylosing spondylitis and HlA 27. Lancet 301(7809):904–907. https://doi.org/10.1016/S0140-6736(73)91360-3 CrossRef

15.

Schlosstein L, Terasaki P, Bluestone R, Pearson C (1973) High association of an HLA antigen, W27 with ankylosing spondylitis. N Engl J Med 288(14):704–705. https://doi.org/10.1056/NEJM197304052881403 CrossRefPubMed

16.

Vazquez-Torres A, Vallance B, Bergman M, Finlay B, Cookson B, Jones-Carson J et al (2004) Toll-like receptor 4 dependence of innate and adaptive immunity to salmonella: importance of the Kupffer cell network. J Immunol 172(10):6202–6208. https://doi.org/10.4049/jimmunol.172.10.6202 CrossRefPubMed

17.

Reveille JD (2014) An update on the contribution of the MHC to as susceptibility. Clin Rheumatol 33(6):749–757. https://doi.org/10.1007/s10067-014-2662-7 CrossRefPubMedPubMedCentral

18.

Tsui F, Xi N, Rohekar S, Riarh R, Bilotta R, Tsui H et al (2008) Toll-like receptor 2 variants are associated with acute reactive arthritis. Arthritis Rheum 58(11):3436–3438. https://doi.org/10.1002/art.23967 CrossRefPubMed

19.

Rihl M, Klos A, Köhler L, Kuipers J (2006) Reactive arthritis. Best Pract Res Clin Rheumatol 20(6):1119–1137. https://doi.org/10.1016/j.berh.2006.08.008 CrossRefPubMed

20.

Denison H, Curtis E, Clynes M, Bromhead C, Dennison E, Grainger R (2016) The incidence of sexually acquired reactive arthritis: a systematic literature review. Clin Rheumatol 35(11):2639–2648. https://doi.org/10.1007/s10067-016-3364-0 CrossRefPubMedPubMedCentral

21.

Asquith M, Rosenbaum J (2016) The interaction between host genetics and the microbiome in the pathogenesis of spondyloarthropathies. Curr Opin Rheumatol 28(4):405–412. https://doi.org/10.1097/BOR.0000000000000299 CrossRefPubMed

22.

Reveille JD (2012) Genetics of spondyloarthritis—beyond the MHC. Nat Rev Rheumatol 8(5):296–304. https://doi.org/10.1038/nrrheum.2012.41 CrossRefPubMed

23.

Pope J, Krizova A, Garg A, Thiessen-Philbrook H, Ouimet J (2007) Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 37(1):48–55. https://doi.org/10.1016/j.semarthrit.2006.12.006 CrossRefPubMedPubMedCentral

24.

Zeidler H, Hudson A (2016) Coinfection of chlamydiae and other bacteria in reactive arthritis and spondyloarthritis: need for future research. Microorganisms 4(3):30. https://doi.org/10.3390/microorganisms4030030 CrossRefPubMedCentral

25.

Carter J, Inman R (2011) Chlamydia-induced reactive arthritis: hidden in plain sight? Best Pract Res Clin Rheumatol 25(3):359–374. https://doi.org/10.1016/j.berh.2011.05.001 CrossRefPubMed

26.

Gaston J (2005) Shigella induced reactive arthritis. Ann Rheum Dis 64(4):517–518. https://doi.org/10.1136/ard.2004.030395 CrossRefPubMedPubMedCentral

27.

Cargnelutti E, Di Genaro M (2013) Reactive arthritis: from clinical features to pathogenesis. Int J Clin Med 4(12):20–30. https://doi.org/10.4236/ijcm.2013.412A2004 CrossRef

28.

Garcia H, Azan A, Iraheta I, Von Feldt J, Espinoza L, Manasson J, Scher J, García Kutzbach A (2017) Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up. Clin Rheumatol. https://doi.org/10.1007/s10067-017-3911.3 [Epub ahed of print]

29.

Van de Wiele T, Van Praet J, Marzorati M, Drennan M, Elewaut D (2016) How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol 12(7):398–411. https://doi.org/10.1038/nrrheum.2016.85 CrossRefPubMed

30.

Caminer A, Haberman R, Scher J (2017) Human microbiome, infections, and rheumatic disease. Clin Rheumatol 36(12):2645–2653. https://doi.org/10.1007/s10067-017-3875-3 CrossRefPubMed

31.

Brown J, Hazen S (2015) The gut microbial endocrine organ: bacterially-derived signals driving cardiometabolic diseases. Annu Rev Med 66(1):343–359. https://doi.org/10.1146/annurev-med-060513-093205 CrossRefPubMedPubMedCentral

32.

Eckburg P, Bik E, Bernstein C, Purdom E, Dethlefsen L, Sargent M, Gill S, Nelson K, Relman D (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638. https://doi.org/10.1126/science.1110591 CrossRefPubMedPubMedCentral

33.

Blaser M, Bork P, Fraser C, Knight R, Wang J (2013) The microbiome explored: recent insights and future challenges. Nat Rev Microbiol 11(3):213–217. https://doi.org/10.1038/nrmicro2973 CrossRefPubMed

34.

Catrina A, Deane K, Scher J (2016) Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis. Rheumatology 55(3):391–402. https://doi.org/10.1093/rheumatology/keu469 PubMed

35.

Wendling D, Prati C (2017) Spondyloarthritis: an expanding cast of cellular actors. Jt bone Spine:1–3. https://doi.org/10.1016/j.jbspin.2017.05

36.

Ericsson A, Hagan C, Davis D, Franklin C (2014) Segmented filamentous bacteria: commensal microbes with potential effects on research. Comp Med 64(2):90–98PubMedPubMedCentral

37.

Ji B, Nielsen J (2015) New insight into the gut microbiome through metagenomics. Adv Genomics Genet 5:77–91. https://doi.org/10.2147/AGG.S57215

38.

Ivanov I, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485–498. https://doi.org/10.1016/j.cell.2009.09.033 CrossRefPubMedPubMedCentral

39.

Miossec P (2017) Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice. RMD 3(1):e000284. https://doi.org/10.1136/rmdopen-2016-000284 CrossRef

40.

Riente L, Sedie A, Filippucci E, Iagnocco A, Meenagh G, Grassi W, Valesini G, Bombardieri S (2007) Ultrasound imaging for the rheumatologist IX. Ultrasound imaging in spondyloarthritis. Clin Exp Rheumatol 25(3):349–353PubMed

41.

Colmegna I, Espinoza L (2005) Recent advances in reactive arthritis. Curr Rheumatol Rep 7(3):201–207. https://doi.org/10.1007/s11926-996-0040-4 CrossRefPubMed

42.

Allen-Vercoe E, Reid G, Viner N, Gloor G, Hota S, Kim P, Lee C, O’Doherty K, Vanner S, Weewe S, Petrof E (2012) A Canadian working group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol 26(7):457–462. https://doi.org/10.1155/2012/213828

Titel: Reactive arthritis: update 2018
verfasst von: A. García-Kutzbach
J. Chacón-Súchite
H. García-Ferrer
I. Iraheta
Publikationsdatum: 17.02.2018
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 4/2018
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-018-4022-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Reactive arthritis: update 2018

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

The value of high-sensitivity C-reactive protein in hand and knee radiographic osteoarthritis: data from the Dong-gu Study

Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs

Sleep in ankylosing spondylitis and non-radiographic axial spondyloarthritis: associations with disease activity, gender and mood

Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis

Psoriatic arthritis: tissue-directed inflammation?

IRAK2 is associated with susceptibility to rheumatoid arthritis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin